-+ 0.00%
-+ 0.00%
-+ 0.00%

Stifel Maintains Hold on RxSight, Lowers Price Target to $9

Benzinga·03/09/2026 12:46:20
Listen to the news
Stifel analyst Tom Stephan maintains RxSight (NASDAQ:RXST) with a Hold and lowers the price target from $10 to $9.